Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LQ.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LQ.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XDK.5ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
XDK.5ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XDK.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDK.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDK.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDK.5NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JN.1.4.8ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.1.4.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.1.4.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.4.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.4.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.4.8NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
KP.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
KP.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KP.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XDK.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
XDK.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XDK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDK.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDK.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
KP.5ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
KP.5ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KP.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.5NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XDP.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
XDP.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XDP.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDP.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDP.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDP.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
KP.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
KP.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KP.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JN.1.31ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
JN.1.31ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JN.1.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.31NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.31NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used